Work

Abstract B272: The novel PIM kinase inhibitor SGI-1776 significantly enhances the preclinical activity of sunitinib in renal cell carcinoma

Year: 2009

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-09-b272

Authors: Devalingam Mahalingam, Ernest Medina, Ronan T. Swords, Kevin R. Kelly, David Bearss, Gavin Choy, Pietro Taverna, Jennifer S. Carew, Francis J. Giles, Steffan T. Nawrocki

Institutions: The University of Texas at San Antonio Health Science Center, SuperGen (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2091048080

Cites:

Cited by:

Related to: 10